Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain

被引:39
作者
Túnez, I [1 ]
Muñoz, MD [1 ]
Feijóo, M [1 ]
Muñoz-Castañeda, JR [1 ]
Bujalance, I [1 ]
Valdelvira, ME [1 ]
López, PM [1 ]
机构
[1] Univ Cordoba, Sch Med, Dept Biochem & Mol Biol, E-14004 Cordoba, Spain
关键词
melatonin; neurodegenarative disease; okadaic acid; oxidative stress;
D O I
10.1034/j.1600-079X.2003.00039.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the effect of melatonin on the oxidative changes produced by the intracerebroventricular (i.c.v.) injection of okadaic acid (200 ng/kg BW) in the Wistar rat. The effects of okadaic acid were evaluated as changes in the quantity of lipid peroxides, reduced glutathione content (GSH) and activity of antioxidative enzymes. Okadaic acid caused lipid peroxidation (5.35 +/- 0.47 mu mol/g tissue in the i.c.v. vehicle group versus 10.14 +/- 0.88 mu mol/g tissue in the okadaic acid group, P < 0.001), GSH consumption (0.115 +/- 0.0065 mu mol/g tissue in the i.c.v. vehicle group versus 0.024 +/- 0.0021 mu mol/g tissue, P < 0.001), and a reduction in the activity of GSH-peroxidase, GSH-reductase and GSH-transferase between 60-80%. All these changes were prevented by pre-injection of 4.5 mg melatonin per kg BW 2 hr before okadaic acid. These findings indicate: (i) okadaic acid induces a status of oxidative stress in the brain, characterized by a high level of lipid peroxidation, decreases in GSH content and diminished activities of antioxidative enzymes, and (ii) melatonin prevents the deleterious effects induced by okadaic acid. In conclusion, the results show the ability of melatonin to modify the neural response to okadaic acid with the protective mechanism likely involving the antioxidative processes of melatonin.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 34 条
[21]  
Pappolla MA, 1997, J NEUROSCI, V17, P1683
[22]   An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease [J].
Pappolla, MA ;
Chyan, YJ ;
Poeggeler, B ;
Frangione, B ;
Wilson, G ;
Ghiso, J ;
Reiter, RJ .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (02) :203-231
[23]  
Pellegrino L.J., 1981, STEREOTAXIC ATLAS RA
[24]   Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal [J].
Pérez, M ;
Cuadros, R ;
Smith, MA ;
Perry, G ;
Avila, J .
FEBS LETTERS, 2000, 486 (03) :270-274
[25]  
POZO D, 1994, LIFE SCI, V55, P455
[26]   Pharmacological actions of melatonin in oxygen radical pathophysiology [J].
Reiter, R ;
Tang, L ;
Garcia, JJ ;
MunozHoyos, A .
LIFE SCIENCES, 1997, 60 (25) :2255-2271
[27]   Melatonin, active oxygen species and neurological damage [J].
Reiter, RJ .
DRUG NEWS & PERSPECTIVES, 1998, 11 (05) :291-296
[28]   Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinsonism [J].
Reiter, RJ ;
Cabrera, J ;
Sainz, RM ;
Mayo, JC ;
Manchester, LC ;
Tan, DX .
NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 :471-485
[29]   Oxidative damage in the central nervous system: Protection by melatonin [J].
Reiter, RJ .
PROGRESS IN NEUROBIOLOGY, 1998, 56 (03) :359-384
[30]  
REITER RJ, 1993, NEUROENDOCRINOL LETT, V15, P103